Protamine Sulfate (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Protamine Sulfate drug offered from Fresenius Kabi USA, LLC. This Heparin Binding Activity [MoA],Heparin Reversal Agent [EPC],Reversed Anticoagulation Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | PROTAMINE SULFATE |
| SUBSTANCE NAME: | PROTAMINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Heparin Binding Activity [MoA],Heparin Reversal Agent [EPC],Reversed Anticoagulation Activity [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2000-10-18 |
| END MARKETING DATE: | 0000-00-00 |
Protamine Sulfate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Protamine Sulfate from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2000-10-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-229_5376a17a-8e5a-4047-8dc7-8a312982c6a1 |
| PRODUCT NDC: | 63323-229 |
| APPLICATION NUMBER: | ANDA089454 |
Other PROTAMINE SULFATE Pharmaceutical Manufacturers / Labelers:
